Skip to content
Screener

Bio-Rad Laboratories BIO Q1 2026 earnings

Reported April 30, 2026 · After market close

Revenue$592.1MBeat by $2.2M
EPS$1.89Miss by $0.10
Revenue estimate$589.9M
EPS estimate$1.99

Next report

Oct 29, 2026 (in a month)
Revenue estimate$650.6M
EPS estimate$2.23

Financials

Q1 2026

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$7.52B+10.3%
Enterprise value$8B+4.2%
P/E44.6×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Segments

By geography

See full
Europe$206.8M+3.5%
Asia Pacific$110.4M+6.1%
Americas$45.1M+13.3%

By segment

See full
Clinical Diagnostics$363.6M+1.9%
Life Science$228.5M0.0%

FAQ

When did Bio-Rad Laboratories report Q1 2026 earnings?
Bio-Rad Laboratories (BIO) reported Q1 2026 earnings on April 30, 2026 after market close.
What were Bio-Rad Laboratories's Q1 2026 revenue and EPS?
Bio-Rad Laboratories reported revenue of $592.1M and eps of $1.89 for Q1 2026.
Did Bio-Rad Laboratories beat estimates in Q1 2026?
Revenue beat the consensus estimate of $589.9M by $2.2M. EPS missed the consensus estimate of $1.99 by $0.10.
How did Bio-Rad Laboratories's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.1% from $585.4M a year earlier and eps declined 25.6% from $2.54.
Where can I find Bio-Rad Laboratories's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000012208-26-000034) and the 10-Q periodic report (0000012208-26-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.